07.07.2015 • News

HCS Group Concludes Refinancing

HCS Group, a Germany-based global manufacturer of hydrocarbon and chemical specialty products, has successfully concluded its refinancing.

The new financial structure with a volume of €170 million and a duration of five years provides a solid foundation for the group’s planned strategic development during the coming years, HCS said.

The separate financing of the subsidiaries in Germany and the UK has been replaced by refinancing at group level, enabling a future depth of integration that creates the conditions for future growth, said CFO Peter Stubbe.

“In addition, we were able to reduce the financing costs significantly,” Stubbe stated. “We are continuing to evolve rapidly into an international customer-orientated specialty chemicals company.”

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.